Replies to post #211926 on Biotech Values

[maverick_1]

The single best elaboration I've come across on the HUGE Complexities that CONFRONT the US Heath Care Developing Crisis that will have the US economy in a tight stranglehold came from the appearance of these two EXPERTS: Ezra Klein of Vox Media and Peter Orzag, the global co-head of health care at Lazard, discuss the Congressional Budget Office's analysis of the American Health Care Act bill.

The latter section of:
https://charlierose.com/episodes/30526?autoplay=true

In addition to the above think about these major developments
1)The Diabetes Epidemic
2) The Opoid Epidemic
3) Alarming Impact of Alzheimers

IF one hasn't read these, one should:
Steven Brill: America's Bitter Pil
Elizabeth Rosenthal: An American Sickness

DIFFERENT STROKES FOR DIFFERENT FOLKS

[CHM_760]

The White House reports that only a meeting on the subject is taking place; no assurance of an actual Executive Order.

I own a couple of biotechs that are especially sensitive to rumors about price controls (ACAD for one).

In today's world, just the mention of a meeting is enough to dump the IBB/XBI by 2%-3% in a matter of minutes, which is when I posted that little blurb.